2% Lidocaine Hci Injection, Solution
Product Images NDC 51662-1231

7 FDA label images from Hf Acquisition Co. Llc, Dba Health First · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for 2% Lidocaine Hci (NDC 51662-1231). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hf Acquisition Co. Llc, Dba Health First, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Serialized Label (51662 1231 1 Lidocaine 100mg Serialized Label On Box)

Serialized Label (51662 1231 1 Lidocaine 100mg Serialized Label On Box)
2% LIDOCAINE HCI injection, solution for intravenous use in a box labeled with 20 mg/mL strength and 100 mg total dosage. Distributed by HF Acquisition Co., LLC DBA Health First, Mukilteo, WA. The packaging includes storage instructions and needle safety warnings.*
FDA Label Image

5ml Syringe Label (5ml Syringe Label)

5ml Syringe Label (5ml Syringe Label)
Label for 2% Lidocaine HCl Injection, USP, 100 mg/5 mL single-dose vial. The label includes a red highlighted section with the strength and concentration and dosage scale markings in mL. It notes that the product contains no preservatives, is sterile, nonpyrogenic, and intended for I.V. cardiac arrhythmia use. The manufacturer is Hospira, Inc., Lake Forest, IL, USA.*
FDA Label Image

Syringe Box (5ml Syr Box)

Syringe Box (5ml Syr Box)
Packaging label for 2% Lidocaine HCI Injection, USP, 100 mg/5 mL in a 5 mL glass unit dose syringe with male luer lock adapter and 20-Gauge protected needle. The label includes usage instructions, handling cautions, and is labeled for intravenous use in cardiac arrhythmias. The product is manufactured by HF Acquisition Co. LLC, DBA Health First, with NDC 51662-1231.*
FDA Label Image

Availability (Availability)

Availability (Availability)
A data table presenting Lidocaine Hydrochloride injection information with columns for volume (total lidocaine HCl), concentration in mg/mL, and pH. It includes two rows: one for direct intravenous injection (5 mL with 20 mg/mL concentration, pH 5.0 to 7.0) and one single-dose option (5 mL with 10 mg/mL concentration, pH 5.0 to 7.0).*
FDA Label Image

How Supplied Table (How Supplied)

How Supplied Table (How Supplied)
A data table listing NDC numbers, container types, concentration, size, and total mg for 2% Lidocaine HCl injection solution. It includes single-dose containers such as Ansyr plastic syringes and LifeShield Abbocject syringes with male luer lock adapters, showing concentrations of 2% (20 mg/mL) and 1% (10 mg/mL) in 5 mL vial sizes with total mg amounts of 100 or 50 respectively.*
FDA Label Image
FDA Label Image

Structure (Structure)

Structure (Structure)
Chemical structure of lidocaine hydrochloride monohydrate, showing the aromatic ring with two methyl groups and the amide linkage to a diethylaminoethyl side chain, including hydrochloride and water components.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.